FEATURES OF SEVERE COURSE AND FATAL OUTCOMES OF COMMUNITY-ACQUIRED PNEUMONIA AT THE EXAMPLE OF KRASNOYARSK REGION
https://doi.org/10.36604/1998-5029-2019-74-26-33
Abstract
Introduction. Severe community-acquired pneumonia is one of the most important medical problems
due to its prevalence and high mortality. A total of 705 lethal cases with severe community-acquired pneumonia for 2014-2017 were analyzed on the Krasnoyarsk territory. Aim. To determine the risk factors for the development of deaths in severe community-acquired pneumonia in the Krasnoyarsk territory over a given period. Results. When analyzing patients with severe community-acquired pneumonia, the prevalence of men was found – 461 cases, the average age of the patients was 62 years old. After analyzing patients’ adherence to smoking, injecting drug use, alcohol abuse, it was found out that 180 patients smoked (25.53±1.64%), 177 (25.1±1.6%) patients abused alcohol, 58 injected drugs (8.2±1.0%). In 75.18±1.63% cases, bilateral lung lesions were recorded. Almost half (53.76%) of patients had comorbidities: chronic diseases of the cardiovascular system in 30.21%, chronic lung diseases in 15.46%, diabetes in 8.79%, chronic viral hepatitis and liver cirrhosis 4.54%, HIV infection in 6.81%. In patients aged 18-44 years, HIV infection, chronic viral hepatitis, and liver cirrhosis were more common. Starting at the age of 45, chronic diseases of the cardiovascular system were more frequently recorded. As a result of the analysis of patient management, it was found out that along with an underestimation of the severity of the condition, antibiotic therapy, which corresponds to the clinical guidelines, was prescribed only in 53% of cases. Conclusion. It is important in the supervision of patients with severe community-acquired pneumonia to assess all risk factors, as well as analyze the comorbidities which will lead to the correct choice of therapy in accordance with clinical guidelines.
due to its prevalence and high mortality. A total of 705 lethal cases with severe community-acquired pneumonia for 2014-2017 were analyzed on the Krasnoyarsk territory. Aim. To determine the risk factors for the development of deaths in severe community-acquired pneumonia in the Krasnoyarsk territory over a given period. Results. When analyzing patients with severe community-acquired pneumonia, the prevalence of men was found – 461 cases, the average age of the patients was 62 years old. After analyzing patients’ adherence to smoking, injecting drug use, alcohol abuse, it was found out that 180 patients smoked (25.53±1.64%), 177 (25.1±1.6%) patients abused alcohol, 58 injected drugs (8.2±1.0%). In 75.18±1.63% cases, bilateral lung lesions were recorded. Almost half (53.76%) of patients had comorbidities: chronic diseases of the cardiovascular system in 30.21%, chronic lung diseases in 15.46%, diabetes in 8.79%, chronic viral hepatitis and liver cirrhosis 4.54%, HIV infection in 6.81%. In patients aged 18-44 years, HIV infection, chronic viral hepatitis, and liver cirrhosis were more common. Starting at the age of 45, chronic diseases of the cardiovascular system were more frequently recorded. As a result of the analysis of patient management, it was found out that along with an underestimation of the severity of the condition, antibiotic therapy, which corresponds to the clinical guidelines, was prescribed only in 53% of cases. Conclusion. It is important in the supervision of patients with severe community-acquired pneumonia to assess all risk factors, as well as analyze the comorbidities which will lead to the correct choice of therapy in accordance with clinical guidelines.
About the Authors
N. V. Gordeeva
Krasnoyarsk State Medical University; Krasnoyarsk Regional Clinical Hospital
Russian Federation
Russian Federation
MD, PhD (Med.), Associate Professor of Department of Internal Medicine and Immunology with Postgraduate Education Course, Pulmonologist
1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022, Russian Federation
3a Partizana Zheleznyaka Str., Krasnoyarsk, 660022, Russian Federation
I. V. Demko
Krasnoyarsk State Medical University;
Krasnoyarsk Regional Clinical Hospital
Russian Federation
Russian Federation
MD, PhD, D.Sc. (Med.), Professor, Head of Department
of Internal Medicine and Immunology with Postgraduate Education
Course, Head of Pulmonary Allergology Сenter
1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022, Russian Federation
3a Partizana Zheleznyaka Str., Krasnoyarsk, 660022, Russian Federation
E. E. Korchagin
Krasnoyarsk Regional Clinical Hospital
Russian Federation
Russian Federation
MD, Chief Physician
3a Partizana Zheleznyaka Str., Krasnoyarsk, 660022, Russian Federation
I. A. Soloveva
Krasnoyarsk State Medical University;
Krasnoyarsk Regional Clinical Hospital
Russian Federation
Russian Federation
MD, PhD, D.Sc. (Med.), Associate Professor of Department of Internal Medicine and Immunology with Postgraduate Education Course, Pulmonologist
1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022, Russian Federation
3a Partizana Zheleznyaka Str., Krasnoyarsk, 660022, Russian Federation
A. Yu. Kraposhina
Krasnoyarsk State Medical University;
Krasnoyarsk Regional Clinical Hospital
Russian Federation
Russian Federation
MD, PhD (Med.), Associate Professor of Department of Internal Medicine and Immunology with Postgraduate Education Course, Pulmonologist
1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022, Russian Federation
3a Partizana Zheleznyaka Str., Krasnoyarsk, 660022, Russian Federation
M. G. Mamaeva
Krasnoyarsk State Medical University;
Krasnoyarsk Regional Clinical Hospital
Russian Federation
Russian Federation
MD, PhD (Med.), Assistant of Department of Internal Medicine and Immunology with Postgraduate Education Course, Pulmonologist
1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022, Russian Federation
3a Partizana Zheleznyaka Str., Krasnoyarsk, 660022, Russian Federation
N. Yu. Pavlova
Krasnoyarsk State Medical University
Russian Federation
Russian Federation
MD, PhD (Med.), Associate Professor of Department of Internal Medicine and Immunology with Postgraduate Education Course
1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022, Russian Federation
3a Partizana Zheleznyaka Str., Krasnoyarsk, 660022, Russian Federation
A. A. Novikova
Krasnoyarsk Regional Clinical Hospital
Russian Federation
Russian Federation
MD, Pulmonologist
3a Partizana Zheleznyaka Str., Krasnoyarsk, 660022, Russian Federation
E. A. Verbitskaya
Krasnoyarsk State Medical University
Russian Federation
Russian Federation
MD, PhD (Med.), Resident of Department of Internal Medicine and Immunology with Postgraduate Education Course
1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022, Russian Federation
D. A. Anikin
Krasnoyarsk State Medical University
Russian Federation
Russian Federation
MD, PhD (Med.), Resident of Department of Internal Medicine and Immunology with Postgraduate Education Course
1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022, Russian Federation
References
1. Borodulin B.E., Chernogaeva G.Yu., Borodulina E.A., Povalyaeva L.V., Victor N.N. Lethality from community-acquired pneumonia in multi-field hospital for the period of 10 years. Meditsinskiy alʹmanakh 2012; 21(2):34–36 (in Russian).
2. Borodulina E.A., Borodulin B.E., Povaljaeva L.V., Chernogaeva G.Yu., Vdoushkina E.S. Predictors of mortality from community-acquired pneumonia in the modern conditions of pulmonology center. The Bulletin of Contemporary Clinical Medicine 2015; 8(4):19–22 (in Russian).
3. Kruglyakova L.V., Naryshkina S.V. Peculiarities of the course and outcomes of community acquired pneumo-nia according to the data of Blagoveshchensk City Clinical Hospital (2009-2014). Bûlleten' fiziologii i patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2015; 57:42–48 (in Russian).
4. Kruglyakova L.V., Naryshkina S.V. Severe community-acquired pneumonia: diagnostics and treatment (review). Bûlleten' fiziologii i patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2016; 59:98–108 (in Russian).
5. Popova N.M., Shklyaev A.E., Lyalina A.S., Mokshina P.S., Khisamutdinova A.M. Risk factors for death from pneumonia. Sinergiya nauk 2016; 6:750–755 (in Russian). Available at: http://synergy-journal.ru/archive/article0110
6. Sinopalnikov A.I. Severe community-acquired pneumonia. Ehffektivnaya farmakoterapiya 2014; 40:4–27 (in Russian).
7. Sorokin E.P., Ponomarev S.V., Ivanova V.V., Shilyaeva Ye.V. Assessment of risk factor for developing pneumonia in patients with thoracoabdominal injuries. Sibirskoe medicinskoe obozrenie 2016; 1: 56–60 (in Russian).
8. Khamitov R.F., Palʹmova L.Yu., Sulbaeva K.R. Severe pneumonia in clinical practice. Kazanskiy meditsinskiy zhurnal 2016; 97(6):994–999 (in Russian). doi: https://doi.org/10.17750/KMJ2016-994
Review
For citations:
Gordeeva N.V., Demko I.V., Korchagin E.E., Soloveva I.A., Kraposhina A.Yu., Mamaeva M.G., Pavlova N.Yu., Novikova A.A., Verbitskaya E.A., Anikin D.A. FEATURES OF SEVERE COURSE AND FATAL OUTCOMES OF COMMUNITY-ACQUIRED PNEUMONIA AT THE EXAMPLE OF KRASNOYARSK REGION. Bulletin Physiology and Pathology of Respiration. 2019;(74):26-33. (In Russ.) https://doi.org/10.36604/1998-5029-2019-74-26-33
Views:
427
Email this article 